FDA Approves First Drug for Common, Serious Liver Disease
FRIDAY, March 15, 2024 (HealthDay News) — Millions of Americans whose livers develop scar tissue due to a common disease now have the first approved drug, Rezdiffra, to treat the condition, the U.S. Food and Drug Administration announced Thursday. The condition is called non-cirrhotic non-alcoholic steatohepatitis (NASH). NASH with liverContinue Reading